Hospitalized patients who were taking daily aspirin had lower risk of ICU admission, ventilation, and dying from SARS-CoV-2 virus.
Hospitalized COVID-19 patients who were taking a daily low-dose aspirin to protect against cardiovascular disease had a significantly lower risk of complications and death compared to those who were not taking aspirin, according to a new study led by researchers at the University of Maryland School of Medicine (UMSOM).
Aspirin takers were less likely to be placed in the intensive care unit (ICU) or hooked up to a mechanical ventilator, and they were more likely to survive the infection compared to hospitalized patients who were not taking aspirin, The study, published on October 21, 2020, in the journal Anesthesia and Analgesia, provides “cautious optimism,” the researchers say, for an inexpensive, accessible medication with a well-known safety profile that could help prevent severe complications.
Chow and his colleagues culled through the medical records of 412 COVID-19 patients, age of 55 on average, who were hospitalized over the past few months due to complications of their infection.
About a quarter of the patients were taking a daily low-dose aspirin (usually 81 milligrams) before they were admitted or right after admission to manage their cardiovascular disease.
Doctors often recommend a daily low-dose aspirin for patients who have previously had a heart attack or stroke caused by a blood clot to prevent future blood clots.
“We believe that the blood thinning effects of aspirin provides benefits for COVID-19 patients by preventing microclot formation,” said study co-author Michael A.
“Patients diagnosed with COVID-19 may want to consider taking a daily aspirin as long as they check with their doctor first.” Those at increased bleeding risk due to chronic kidney disease, for example, or because they regularly use certain medications, like steroids or blood thinners, may not be able to safely take aspirin, he added.
“This study adds to the tremendous work our researchers are doing in the School of Medicine to help find new treatments against COVID-19 and save patients’ lives,” said E.
“While confirmatory studies are needed to prove that aspirin use leads to better outcomes in COVID-19, the evidence thus far suggests that patients may want to discuss with their doctor whether it is safe for them to take aspirin to manage potentially prevent serious complications.”.
This article shows that taking aspirin will quicken your blood flow
For some reason blood flow has a lot to do with the severity of the coronavirus illness
Seeing that is so one must speculate that the coronavirus works well in infecting worse those with bad blood flow and bad organs
Diabetics have high sugars in their blood stream for the coronavirus to grow
So maybe if we were to give coronavirus patients a diet that will clean out their bowels
Then give coronavirus patients a 1000 mg
aspirin to speed up their blood flow and do this 2-3 times a day
Maybe if we clean out the digestive system, speed up the blood flow system with aspirin and also give the coronavirus patient 2 extra strength vitamins a day 6 hours apart with a meal that contains all of the 9 amino acids that are needed to make up a protein of any kind that the body needs to make any kind of cell that a human body can make
Just maybe the vitamins and protein rich diet daily with the aspirin will help the body create proteins that will help fight off the problems caused by coronavirus
16 hours ago
16 hours ago
17 hours ago
17 hours ago
Get monthly updates and free resources.
CONNECT WITH US